Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Net Income (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Net Income readings, the most recent being -$6.7 million for Q4 2025.

  • On a quarterly basis, Net Income fell 989.66% to -$6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$56.7 million, a 1.12% decrease, with the full-year FY2025 number at -$56.7 million, down 1.12% from a year prior.
  • Net Income hit -$6.7 million in Q4 2025 for Treace Medical Concepts, up from -$16.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$619000.0 in Q4 2024 to a low of -$21.3 million in Q2 2024.
  • Median Net Income over the past 5 years was -$12.2 million (2022), compared with a mean of -$11.1 million.
  • Biggest five-year swings in Net Income: soared 90.29% in 2024 and later plummeted 989.66% in 2025.
  • Treace Medical Concepts' Net Income stood at -$6.6 million in 2021, then surged by 38.75% to -$4.1 million in 2022, then tumbled by 57.26% to -$6.4 million in 2023, then soared by 90.29% to -$619000.0 in 2024, then plummeted by 989.66% to -$6.7 million in 2025.
  • The last three reported values for Net Income were -$6.7 million (Q4 2025), -$16.4 million (Q3 2025), and -$17.5 million (Q2 2025) per Business Quant data.